Scaling Lifesaving Interventions Faster: A Case Study on the Accelerated Uptake of NOPV2, the First Vaccine to Receive WHO Emergency Use Listing

Scaling Lifesaving Interventions Faster: A Case Study on the Accelerated Uptake of NOPV2, the First Vaccine to Receive WHO Emergency Use Listing

The Launch and Scale Speedometer blog series. November 18, 2021 By Stephanie Stan Scaling Lifesaving Interventions Faster: A case study on the accelerated uptake of nOPV2, the first vaccine to receive WHO Emergency Use Listing  Widespread administration of oral polio vaccines (OPVs)